|
End-of-day quote
Nasdaq
27/10/2026
|
5-day change | 1st Jan Change | ||
| 1.830 USD | +7.65% |
|
-3.68% | -77.01% |
Company Valuation: Elicio Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 80.11 | 54.96 | 139.1 | 44.15 | - | - |
| Change | - | -31.39% | 153.09% | -68.26% | - | - |
| Enterprise Value (EV) | 80.11 | 54.96 | 139.1 | 44.15 | 44.15 | 44.15 |
| Change | - | -31.39% | 153.09% | -68.26% | 0% | 0% |
| P/E | - | -1.2x | -3.09x | -0.9x | -0.99x | -1.4x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.1x | 0x | 0.1x | 0x |
| Capitalization / Revenue | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -1.03x | -0.85x | -0.74x |
| EV / FCF | - | -0x | - | -1.12x | -0.81x | -0.66x |
| FCF Yield | - | -67.6% | - | -89% | -123% | -151% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | -4.25 | -2.58 | -1.87 | -1.69 | -1.2 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -35.74 | -44.99 | -37.71 | -42.79 | -51.84 | -59.8 |
| Net income 1 | - | -51.9 | -39.57 | -42.06 | -52.78 | -59.7 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 8.340 | 5.100 | 7.960 | 1.680 | 1.680 | 1.680 |
| Nbr of stocks (in thousands) | 9,606 | 10,777 | 17,475 | 26,282 | - | - |
| Announcement Date | 29/03/24 | 31/03/25 | 12/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.9x | - | - | - | 44.15M | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -70.14x | 13.02x | -68.47x | -.--% | 24.7B | |
| Average | 15.66x | 28.01x | 7.09x | 0.34% | 39.44B | |
| Weighted average by Cap. | 21.73x | 26.34x | 11.23x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ELTX Stock
- Valuation Elicio Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
